Cargando…
Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery
[Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based n...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835629/ https://www.ncbi.nlm.nih.gov/pubmed/36643539 http://dx.doi.org/10.1021/acsomega.2c05976 |
_version_ | 1784868706615033856 |
---|---|
author | Priya, Sakshi Desai, Vaibhavi Meghraj Singhvi, Gautam |
author_facet | Priya, Sakshi Desai, Vaibhavi Meghraj Singhvi, Gautam |
author_sort | Priya, Sakshi |
collection | PubMed |
description | [Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid-based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work. |
format | Online Article Text |
id | pubmed-9835629 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-98356292023-01-13 Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery Priya, Sakshi Desai, Vaibhavi Meghraj Singhvi, Gautam ACS Omega [Image: see text] Nanocarriers have the utmost significance for advancements in drug delivery and nanomedicine technology. They are classified as polymer-based nanocarriers, lipid-based nanocarriers, viral nanoparticles, or inorganic nanoparticles, depending on their constituent parts. Lipid-based nanocarrier systems have gained tremendous attention over the years because of their noteworthy properties like high drug-loading capacity, lower toxicity, better bioavailability and biocompatibility, stability in the gastrointestinal tract, controlled release, simpler scale-up, and validation process. Nanocarriers still have some disadvantages like poor drug penetration, limited drug encapsulation, and poor targeting. These disadvantages can be overcome by their surface modification. Surface-modified nanocarriers result in controlled release, enhanced penetration efficiency, and targeted medication delivery. In this review, the authors summarize the numerous lipid-based nanocarriers and their functionalization through various surface modifiers such as polymers, ligands, surfactants, and fatty acids. Recent examples of newly developing surface-modified lipid-based nanocarrier systems from the available literature, along with their applications, have been compiled in this work. American Chemical Society 2022-12-20 /pmc/articles/PMC9835629/ /pubmed/36643539 http://dx.doi.org/10.1021/acsomega.2c05976 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Priya, Sakshi Desai, Vaibhavi Meghraj Singhvi, Gautam Surface Modification of Lipid-Based Nanocarriers: A Potential Approach to Enhance Targeted Drug Delivery |
title | Surface Modification
of Lipid-Based Nanocarriers:
A Potential Approach to Enhance Targeted Drug Delivery |
title_full | Surface Modification
of Lipid-Based Nanocarriers:
A Potential Approach to Enhance Targeted Drug Delivery |
title_fullStr | Surface Modification
of Lipid-Based Nanocarriers:
A Potential Approach to Enhance Targeted Drug Delivery |
title_full_unstemmed | Surface Modification
of Lipid-Based Nanocarriers:
A Potential Approach to Enhance Targeted Drug Delivery |
title_short | Surface Modification
of Lipid-Based Nanocarriers:
A Potential Approach to Enhance Targeted Drug Delivery |
title_sort | surface modification
of lipid-based nanocarriers:
a potential approach to enhance targeted drug delivery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9835629/ https://www.ncbi.nlm.nih.gov/pubmed/36643539 http://dx.doi.org/10.1021/acsomega.2c05976 |
work_keys_str_mv | AT priyasakshi surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery AT desaivaibhavimeghraj surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery AT singhvigautam surfacemodificationoflipidbasednanocarriersapotentialapproachtoenhancetargeteddrugdelivery |